News
The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association's 85th ...
Glucotrack today announced the results from the first-in-human clinical study of its long-term continuous blood glucose ...
(Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results